HIT Consultant December 9, 2025
Doug Besch, Chief Product and Chief Technology Officer at OptimizeRx

Consumers are increasingly learning about potential drug therapies from advertising across the media channels they use regularly – whether it be broadcast or streaming TV, social media, display ads, or streaming radio. One survey found that 63% of patients learned about new treatments through pharmaceutical ads, but capturing and retaining consumer attention continues to be an uphill battle for pharmaceutical marketers, with many consumers experiencing advertising saturation and fatigue. Life sciences marketers are scrambling to find innovative ways to individualize customer interactions across multiple channels, whether that be digital or traditional direct-to-consumer (DTC) media.

AI and machine learning are emerging as powerful tools to facilitate smarter, more targeted marketing outreach. In fact, over 70% of brands agree that AI will...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: AI (Artificial Intelligence), Biotechnology, Pharma, Pharma / Biotech, Technology
What’s new with GLP-1s
Navigating the Shift: 2026 Medicare Drug Pricing and the Future of Pharmacy
Podcast: Medicaid vs. 340B: A Drug Pricing Clash (Sayeh Nikpay)
283: A candid conversation: Physicians on the front lines of GLP‑1 care
BigHat, Revvity Collaborate with Eli Lilly, Immunai Signs Agreement with Bristol Myers Squibb, SandboxAQ Launches New AI Model

Share Article